Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 601–700 of 1,011
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., & Sun, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808327200 · Cited by 82
Targeting telomerase-expressing cancer cells
Ouellette, M. M., Wright, W. E., & Shay, J. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01279.x · Cited by 88
Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation
Haurie, V., Durrieu-Gaillard, S., Dumay‐Odelot, H., Silva, D. D., Rey, C., Procházková, M., Roeder, R. G., Besser, D., & Teichmann, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914980107 · Cited by 94
A long view of fashions in cancer research
Harris, H. (2005) · BioEssays · doi:10.1002/bies.20263 · Cited by 84
Immortalization of human small airway epithelial cells by ectopic expression of telomerase
Piao, C. Q., Liu, L., Zhao, Y. L., Balajee, A. S., Suzuki, M., & Hei, T. K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi016 · Cited by 86
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene
Zhu, J., Zhao, Y., & Wang, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0014-1 · Cited by 81
Mayerhofer, M., Gleixner, K. V., Hoelbl, A., Florian, S., Hoermann, G., Aichberger, K. J., Bilban, M., Esterbauer, H., Krauth, M.-T., Sperr, W. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5466 · Cited by 81
Iliopoulos, D., Rotem, A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0425 · Cited by 81
Interaction of an Acridine Dimer with DNA Quadruplex Structures
Alberti, P., Ren, J., Teulade‐Fichou, M., Guittat, L., Riou, J., Chaires, J. B., Hélène, C., Vigneron, J., Lehn, J., & Mergny, J. (2001) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2001.10506758 · Cited by 88
Sheng, W., Decaussin, G., Sumner, S., & Ooka, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204217 · Cited by 82
Nesterov, A., Nikrad, M., Johnson, T., & Kraft, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2219 · Cited by 80
Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis
Mihaljević, A. L., Michalski, C. W., Friess, H., & Kleeff, J. H. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0622-5 · Cited by 97
Lee, J. H., & Chung, I. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.026 · Cited by 81
IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1
Sun, Y., Gao, D., Liu, Y., Huang, J., Lessnick, S. L., & Tanaka, S. (2005) · Oncogene · doi:10.1038/sj.onc.1209143 · Cited by 87
Vonderheide, R. H., Schultze, J. L., Anderson, K. S., Maecker‐Kolhoff, B., Butler, M. O., Xia, Z., Kuroda, M. J., von Bergwelt‐Baildon, M. S., Bedor, M., Hoar, K. M., et al. (2001) · PubMed · Cited by 77
Self-citation2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai, S., Kondo, Y., Koga, S., Komata, T., Barna, B. P., & Kondo, S. (2000) · PubMed · Cited by 88
Burg, G., Dummer, R., Haeffner, A. C., Kempf, W., & Kadin, M. E. (2001) · PubMed · Cited by 80
Kleinstreuer, N. C., Dix, D. J., Houck, K. A., Kavlock, R. J., Knudsen, T. B., Martin, M. T., Paul, K. B., Reif, D. M., Crofton, K. M., Hamilton, K., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs285 · Cited by 79
Cyclotherapy: Protection of Normal Cells and Unshielding of Cancer Cells
Blagosklonny, M. V., & Darzynkiewicz, Z. (2002) · Cell Cycle · doi:10.4161/cc.1.6.259 · Cited by 79
Lee, J. H., Khadka, P., Baek, S. H., & Chung, I. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149831 · Cited by 96
Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells
Tchernitsa, O. I., Sers, C., Zuber, J. A., Hinzmann, B., Grips, M., Schramme, A., Lund, P., Schwendel, A., Rosenthal, A., & Schäfer, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207585 · Cited by 87
Choosing anticancer drug targets in the postgenomic era
Kaelin, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8888 · Cited by 79
Cell Transformation by Human Adenoviruses
Endter, C., & Dobner, T. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05599-1_6 · Cited by 93
Zhang, A., Zheng, C., Hou, M., Lindvall, C., Li, K.-J., Erlandsson, F., Björkholm, M., Gruber, A., Blennow, E., & Xu, D. (2003) · The American Journal of Human Genetics · doi:10.1086/374565 · Cited by 78
Characterization of Interactions between PinX1 and Human Telomerase Subunits hTERT and hTR
Banik, S. S. R., & Counter, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408131200 · Cited by 78
Self-citationReconstructing the molecular life history of gliomas
Barthel, F. P., Wesseling, P., & Verhaak, R. G. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1842-y · Cited by 88
Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2
Cherfils‐Vicini, J., Iltis, C., Cervera, L., Pisano, S., Croce, O., Sadouni, N., Győrffy, B., Collet, R., Renault, V. M., Rey‐Millet, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100012 · Cited by 87
Looijenga, L. H. J., Gillis, A., Stoop, H., Hersmus, R., & Oosterhuis, J. W. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1411.000 · Cited by 83
Wang, Q., Li, D.-C., Zf, L., Liu, C.-X., Xiao, Y.-M., Zhang, B., Li, X.-D., Zhao, J., Chen, L.-P., Xing, X.-M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.103 · Cited by 78
Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model
岩崎, 正., Kuwata, T., Yamazaki, Y., Jenkins, N. A., Copeland, N. G., Osato, M., Ito, Y., KROON, E. J., Sauvageau, G., & Nakamura, T. (2004) · Blood · doi:10.1182/blood-2004-04-1508 · Cited by 77
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties
Pitman, M. R., Powell, J. A., Coolen, C., Moretti, P. A. B., Zebol, J. R., Pham, D., Finnie, J. W., Don, A. S., Ebert, L. M., Bonder, C. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3178 · Cited by 76
Genetic modification of primary human B cells to model high-grade lymphoma
Caeser, R., Re, M. D., Krupka, J. A., Gao, J., Lara‐Chica, M., Dias, J. M. L., Cooke, S. L., Fenner, R. E., Usheva, Z., Runge, H. F. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12494-x · Cited by 90
Hindupur, S. K., & Rangarajan, A. (2009) · Journal of Virology · doi:10.1128/jvi.00603-09 · Cited by 85
Wu, G., Liu, H., He, H., Wang, Y., Lu, X., Yu, Y., Xia, S., Meng, X., & Liu, Y. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-107 · Cited by 83
Ral GTPases: crucial mediators of exocytosis and tumourigenesis
Shirakawa, R., & Horiuchi, H. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvv029 · Cited by 76
A functional genetic screen defines the AKT-induced senescence signaling network
Chan, K. T., Blake, S., Zhu, H., Kang, J., Trigos, A. S., Madhamshettiwar, P. B., Diesch, J., Paavolainen, L., Horvath, P., Hannan, R. D., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0384-8 · Cited by 71
Salicioni, A. M., Gervasi, M. G., Sosnik, J., Tourzani, D. A., Nayyab, S., Caraballo, D. A., & Visconti, P. E. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa064 · Cited by 76
The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes
Saldanha, S. N., & Tollefsbol, T. O. (2011) · Journal of Oncology · doi:10.1155/2012/192464 · Cited by 83
PLA2R1 Mediates Tumor Suppression by Activating JAK2
Vindrieux, D., Augert, A., Girard, C. A., Gitenay, D., Lallet-Daher, H., Wiel, C., Le Calvé, B., Gras, B., Ferrand, M., Verbeke, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0318 · Cited by 75
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
Yamamoto, Y., Ning, G., Howitt, B. E., Mehra, K. K., Wu, L., Wang, X., Yue, H., Kern, F., Wei, T. S., Zhang, T., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4649 · Cited by 75
Palanca-Wessels, M. C., Klingelhutz, A. J., Reid, B. J., Norwood, T. H., Opheim, K. E., Paulson, T. G., Feng, Z., & Rabinovitch, P. S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg076 · Cited by 76
Inhibition of telomerase activity in human cancer cells by RNA interference.
Kosciolek, B. A., Kalantidis, K., Tabler, M., & Rowley, P. T. (2003) · PubMed · Cited by 89
Molecular basis of telomere dysfunction in human genetic diseases
Sarek, G., Marzec, P., Margalef, P., & Boulton, S. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3093 · Cited by 88
From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
Rauner, G., Gupta, P. B., & Kuperwasser, C. (2025) · Nature Methods · doi:10.1038/s41592-025-02769-1 · Cited by 87
Significance of Immunological Detection of Human Telomerase Reverse Transcriptase
Kyo, S., Masutomi, K., Maida, Y., Kanaya, T., Yatabe, N., Nakamura, M., Tanaka, M., Takarada, M., Sugawara, I., Murakami, S., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63446-3 · Cited by 84
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 96
The Human Cancer Genome Project—one more misstep in the war on cancer
Miklos, G. L. G. (2005) · Nature Biotechnology · doi:10.1038/nbt0505-535 · Cited by 76
Cellular Senescence: Ex Vivo p53‐Dependent Asymmetric Cell Kinetics
Rambhatla, L., Bohn, S. A., Stadler, P. B., Boyd, J. T., Coss, R. A., & Sherley, J. L. (2001) · BioMed Research International · doi:10.1155/s1110724301000079 · Cited by 74
PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
Schleicher, E. M., Galvan, A. M., Kawasawa, Y. I., Moldovan, G., & Nicolae, C. M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky658 · Cited by 83
Petraccone, L., Erra, E., Esposito, V., Randazzo, A., Mayol, L., Nasti, L., Barone, G., & Giancola, C. (2004) · Biochemistry · doi:10.1021/bi0300985 · Cited by 76
Models of breast cancer: quo vadis, animal modeling?
Wagner, K. (2003) · Breast Cancer Research · doi:10.1186/bcr723 · Cited by 81
Masutomi, K., & Hahn, W. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00703-6 · Cited by 83
Self-citationHerranz, H., Hong, X., Hùng, N. T., Voorhoeve, P. M., & Cohen, S. M. (2012) · Genes & Development · doi:10.1101/gad.192021.112 · Cited by 83
IFN‐β rescues neurodegeneration by regulating mitochondrial fission via STAT5, PGAM5, and Drp1
Tresse, E., Riera‐Ponsati, L., Jaberi, E., Sew, W. Q. G., Ruscher, K., & Issazadeh‐Navikas, S. (2021) · The EMBO Journal · doi:10.15252/embj.2020106868 · Cited by 79
Cell replacement therapy for Parkinson's disease
Wijeyekoon, R., & Barker, R. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.007 · Cited by 80
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
Meeker, A. K. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.002 · Cited by 81
MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?
Voorhoeve, P. M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.09.003 · Cited by 84
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
Schneider, B. L., & Kulesz-Martin, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh204 · Cited by 83
Potent inhibition of human telomerase by helenalin
Huang, P., Yeh, Y., & Wang, T. V. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.045 · Cited by 77
Park, S.-E., Park, C., Kim, S. H., Hossain, M. A., Kim, M. Y., Chung, H. Y., Son, W. S., Kim, G., Choi, Y. H., & Kim, N. D. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.10.038 · Cited by 74
Stem cell division theory of cancer
López‐Lázaro, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1062330 · Cited by 76
Functional Expression of HGF and Its Receptor in Human Colorectal Cancer
Otte, J.-M., Schmitz, F., Kiehne, K., Stechele, H. U., Banasiewicz, T., Krokowicz, P., Nakamura, T., Fölsch, U. R., & Herzig, K.-H. (2000) · Digestion · doi:10.1159/000007764 · Cited by 73
In Vivo Regulation of hTERT Expression and Telomerase Activity by Androgen.
GUO, C., ARMBRUSTER, B. N., PRICE, D. T., & COUNTER, C. M. (2003) · Journal of Urology · doi:10.1097/01.ju.0000074653.22766.c8 · Cited by 72
Self-citationPerkins, D. J., & Barber, G. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2025-2040.2004 · Cited by 72
BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors
Barbanti‐Brodano, G., Sabbioni, S., Martini, F., Negrini, M., Corallini, A., & Tognon, M. G. (2007) · Advances in experimental medicine and biology · doi:10.1007/0-387-32957-9_23 · Cited by 76
Cdk1, Plks, Auroras, and Neks: The Mitotic Bodyguards
Salaün, P., Rannou, Y., & Prigent, C. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_4 · Cited by 71
Porsch, H., Mehić, M., Olofsson, B., Heldin, P., & Heldin, C.-H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547273 · Cited by 71
Tomlinson, R. L., Abreu, E. B., Ziegler, T. D., Ly, H., Counter, C. M., Terns, R. M., & Terns, M. P. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0184 · Cited by 84
Self-citationKe, X.-S., Qu, Y., Goldfinger, N., Rostad, K., Hovland, R., Akslen, L. A., Rotter, V., Øyan, A. M., & Kalland, K.-H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003368 · Cited by 71
Neupane, M., Clark, A. P., Landini, S., Birkbak, N. J., Eklund, A. C., Lim, E., Culhane, A. C., Barry, W. T., Schumacher, S. E., Beroukhim, R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0341 · Cited by 76
Analysis of 13 32P-DNA Postlabeling Studies on Occupational Cohorts Exposed to Air Pollution
Peluso, M. E. M., Ceppi, M., Munnia, A., Puntoni, R., & Parodi, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.6.546 · Cited by 71
Telomeres, telomerase, and cancer: life on the edge of genomic stability
Oulton, R., & Harrington, L. A. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00013 · Cited by 78
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70
Self-citationZhang, S., Mercado‐Uribe, I., Sood, A. K., Bast, R. C., & Liu, J. (2016) · Genes & Cancer · doi:10.18632/genesandcancer.102 · Cited by 72
Reengineered tricyclic anti-cancer agents
Kastrinsky, D. B., Sangodkar, J., Zaware, N., Izadmehr, S., Dhawan, N. S., Narla, G., & Ohlmeyer, M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.007 · Cited by 70
Nitta, M., Katabuchi, H., Ohtake, H., Tashiro, H., Yamaizumi, M., & Okamura, H. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6084 · Cited by 70
Identification of PITX1 as a TERT Suppressor Gene Located on Human Chromosome 5
Qi, D.-L., Ohira, T., Fujisaki, C., Inoue, T., Ohta, T., Osaki, M., Ohshiro, E., Seko, T., Aoki, S., Oshimura, M., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00470-10 · Cited by 84
CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression
Adler, A. S., Littlepage, L. E., Lin, M., Kawahara, T. L. A., Wong, D. J., Werb, Z., & Chang, H. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3060 · Cited by 72
Allsopp, R., & Weissman, I. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205314 · Cited by 78
Wooten, L. G., Song, P., Senkal, C. E., & Öğretmen, B. (2007) · The FASEB Journal · doi:10.1096/fj.07-8621com · Cited by 69
Immortalization of a primate bipotent epithelial liver stem cell
Allain, J.-É., Dagher, I., Mahieu‐Caputo, D., Loux, N., Andréoletti, M., Westerman, K. A., Briand, P., Franco, D., Leboulch, P., & Weber, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062038599 · Cited by 78
Oligoclonality in Bladder Cancer:: The Implication for Molecular Therapies
Duggan, B. J., Gray, S. B., MCKNIGHT, J. J., Watson, C. J., Johnston, S. R., & Williamson, K. E. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000100105.27708.6c · Cited by 69
Using Aptamers for Cancer Biomarker Discovery
Chang, Y. M., Donovan, M. J., & Tan, W. (2013) · Journal of Nucleic Acids · doi:10.1155/2013/817350 · Cited by 69
XIST RNA Associates with Specific Regions of the Inactive X Chromatin
Gilbert, S. L., Pehrson, J. R., & Sharp, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000409200 · Cited by 69
Riparian ecosystems in human cancers
Alfarouk, K. O., Ibrahim, M. E., Gatenby, R. A., & Brown, J. S. (2013) · Evolutionary Applications · doi:10.1111/eva.12015 · Cited by 69
MacKenzie, K. L., Franco, S., Naiyer, A. J., May, C., Sadelain, M., Rafii, S., & Moore, M. A. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205425 · Cited by 83
Systemic Mastocytosis Associated with Chronic Idiopathic Myelofibrosis
Sotlar, K., Bache, A., Stellmacher, F., Bültmann, B. D., Valent, P., & Horny, H. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070061 · Cited by 72
Adams, D., Bošković, Ž., Thériault, J. R., Wang, A. J., Stern, A. M., Wagner, B. K., Shamji, A. F., & Schreiber, S. L. (2013) · ACS Chemical Biology · doi:10.1021/cb300653v · Cited by 75
Li, N., Yang, R. R., Zhang, W., Dorfman, H. D., Rao, P. H., & Gorlick, R. G. (2009) · Cancer · doi:10.1002/cncr.24519 · Cited by 76
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress
Yang, Y., Gao, Y., Mutter-Rottmayer, L., Zlatanou, A., Durando, M., Ding, W., Wyatt, D. W., Ramsden, D. A., Tanoue, Y., Tateishi, S., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702006 · Cited by 72
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., & Sedivy, J. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2859-2870.2003 · Cited by 68
“Only recently has complete transformation of normal human cells been achieved with defined genetic interventions (17, 18, 34, 51, 81), namely, the expression of hTERT, SV40 LT, SV40 ST, and Ras.”
BackgroundMethodSelf-citationThe cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb
Iness, A. N., Felthousen, J., Ananthapadmanabhan, V., Sesay, F., Saini, S., Guiley, K. Z., Rubin, S. M., Dozmorov, M., & Litovchick, L. (2019) · Oncogene · doi:10.1038/s41388-018-0490-y · Cited by 67
Oncogenic T‐antigen of JC virus is present frequently in human gastric cancers
Shin, S. K., Li, M., Fuerst, F. C., Hotchkiss, E. C., Meyer, R., Kim, T. I., Goel, A., & Boland, C. R. (2006) · Cancer · doi:10.1002/cncr.22028 · Cited by 67
Barradas, M., Gonos, E. S., Zebedee, Z., Kolettas, E., Petropoulou, C., Delgado, M. D., León, J., Hara, E., & Serrano, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5434 · Cited by 76
Richard, C., Lannér, C., Naryzhny, S., Sherman, L., Lee, H., Lambert, P. F., & Zehbe, I. (2010) · Oncogene · doi:10.1038/onc.2010.93 · Cited by 77
Automated velocity mapping of migrating cell populations (AVeMap)
Déforet, M., Parrini, M. C., Petitjean, L., Biondini, M., Buguin, A., Camonis, J., & Silberzan, P. (2012) · Nature Methods · doi:10.1038/nmeth.2209 · Cited by 75
Mack, K. D., Jin, X., Yu, S., Wei, R., Kapp, L. N., Green, C., HERNDIER, B. G., Abbey, N. W., Elbaggari, A., Liu, Y., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200307010-00004 · Cited by 74
Fernandez, P., Scaffidi, P., Markert, E., Lee, J.-H., Rane, S., & Misteli, T. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.069 · Cited by 67
Replicative aging of human articular chondrocytes during ex vivo expansion
Parsch, D., Brümmendorf, T. H., Richter, W., & Fellenberg, J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10626 · Cited by 67
Telomere maintenance mechanisms as a target for drug development
Bearss, D. J., Hurley, L. H., & Hoff, D. D. V. (2000) · Oncogene · doi:10.1038/sj.onc.1204092 · Cited by 76
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.